Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/ae5411df-3593-4a38-856b-8baefeb95722/
RPRX
Royalty Pharma PlcSnapshot 2026-07-26 · 1.0w · Fresh
Strategy Eligibility
5 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
3.7%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 57%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
Vol 17%
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.65
⚡
Risk-Adj Momentum
RAM 3.28
V
Value Analysis
Cheapness relative to fundamentals
18.0%ile
P/E
31.5×
P/S
10.7×
P/B
3.8×
E/P
0.0466
FCF Yield
0.071
EBITDA/EV
0.045
SH Yield
0.037
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
88.00000000
/100 — 1=cheapest
VC2 (Trending Value)
83.00000000
/100
VC3 (Buyback)
84.00000000
/100
P/E of 31.5x is premium-priced — the market is paying up for expected growth. FCF yield of 7.1% is strong — the business generates significant free cash relative to price. VC2 score of 83.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
87.0%ile
ROE
0.120
ROA
0.042
Net Margin
0.339
Op Margin
0.715
GPA
0.123
D/E
1.43
Current
2.66
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.078
Earn Growth
-0.243
Stability
0.635
lower=better
Accruals
-0.092
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
88.0%ile
6M Return
47.0%
12M Return
63.9%
12-1 Mom
56.6%
Risk-Adj
3.28
Vol 252d
17.3%
Vol 60d
40.1%
↑ Expanding
Max DD 12M
-6.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 57% is very strong — a clear uptrend. Risk-adjusted momentum of 3.28 is excellent — strong returns relative to volatility. Near-term vol (40%) is expanding vs long-term (17%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.59
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
6.2%
Sector Quality %ile
88.4%
P/E z-score
0.08
P/B z-score
-0.13
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (87th) and momentum (88th) but expensive (18th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (87th) but expensive (18th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (40%) significantly exceeds 252-day (17%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
42.5% avg (7 factors)
Quality
B
65.9% avg (8 factors)
Momentum
A
99.1% avg (4 factors)
Risk
A
87.9% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.590 | —0 | — | |
| Value %ile | 0.180 | —8 | — | |
| Quality %ile | 0.870 | —8 | — | |
| Momentum %ile | 0.880 | —8 | — | |
| F-Score | 4.000 | —8 | — | |
| Confidence | 0.929 | —8 | — | |
| Volatility | 0.173 | —8 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
31.51
Earnings Yield (E/P)
0.0466
Price / Sales
10.69
Price / Book
3.79
Price / Cash Flow
9.82
FCF Yield
7.1%
EBITDA / EV
4.5%
Sales Yield (1/P·S)
0.0651
Shareholder Yield
Div + net buyback / mktcap
3.7%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
12.0%
Return on Assets
4.2%
Net Margin
33.9%
Operating Margin
71.5%
Gross Profit / Assets
Novy-Marx GPA
12.3%
Debt / Equity
1.43
Current Ratio
2.66
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.092
MomentumPrice trend strength over different horizons
6M Return
47.0%
12M Return
63.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
56.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
3.28
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-24.3%
Earnings Stability (CV)
Lower = more stable
0.635
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
1.5%
Buyback Yield
2.2%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
88
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
83
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
84
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity